Article info
PDFPancreatic cancer
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
- Correspondence to:
Dr Marc Dauer
Medizinische Klinik Innenstadt, University of Munich, Ziemssenstr. 1, 80336 Munich, Germany; marc.dauer{at}med.uni-muenchen.de
Citation
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
Publication history
- Accepted March 22, 2007
- Revised March 20, 2007
- First published March 29, 2007.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Gut